Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis

Original Article

I.B. McInnes, J.K. Anderson, M. Magrey, J.F. Merola, Y. Liu, M. Kishimoto, S. Jeka, C. Pacheco-Tena, X. Wang, L. Chen, P. Zueger, J. Liu, A.L. Pangan, and F. Behrens

N Engl J Med 2021;384:1227-1239

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
03/31/2021
Course expires: 
04/01/2023

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Saturday, April 1, 2023 - 11:59pm.